Incidence and Outcomes of Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Registry-based Descriptive Trial in Kobe City

The current study aims to evaluate the incidence and results of aneurysmal subarachnoid hemorrhage (aSAH) throughout Kobe City. Based on a multicenter retrospective registry-based descriptive trial involving all 13 primary stroke centers in Kobe City, patients with aSAH treated between October 2017...

Full description

Saved in:
Bibliographic Details
Published in:Neurologia Medico-Chirurgica 2023/11/15, Vol.63(11), pp.519-525
Main Authors: OHTA, Tsuyoshi, MATSUMOTO, Shirabe, FUKUMITSU, Ryu, IMAMURA, Hirotoshi, ADACHI, Hidemitsu, HARA, Yoshie, HOSODA, Kohkichi, KIMURA, Hidehito, KUWAYAMA, Kazuyuki, MIZOWAKI, Takashi, MOTOOKA, Yasuhiko, MIYATA, Shiro, SHINODA, Narihide, UENO, Yasushi, YAMAURA, Ikuya, YOSHIDA, Yasuhisa, SAKAI, Chiaki, SAKAI, Nobuyuki
Format: Article
Language:English
Subjects:
Aneurysm
Cardiovascular system
Hydrocephalus
intracranial aneurysm
intracranial vasospasm
Ischemia
Original
Patients
prognosis
Subarachnoid hemorrhage
Vasoconstriction
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The current study aims to evaluate the incidence and results of aneurysmal subarachnoid hemorrhage (aSAH) throughout Kobe City. Based on a multicenter retrospective registry-based descriptive trial involving all 13 primary stroke centers in Kobe City, patients with aSAH treated between October 2017 and September 2019 were studied. A total of 334 patients were included, with an estimated age-adjusted incidence of 11.12 per 100,000 person-years. Curative treatment was given to 94% of patients, with endovascular treatment (51%) preferred over surgical treatment (43%). Of the patients, 12% were treated by shunt surgery for sequential hydrocephalus with a worse outcome at 30 days or discharge (14% vs. 46%, odds ratio (OR): 0.19, 95% confidence interval (CI): 0.088-0.39, p-value
ISSN:0470-8105
1349-8029
DOI:10.2176/jns-nmc.2023-0090